David Mitchell

Plus aucun poste en cours

Profil

David C.
Mitchell formerly worked at Biogen, Inc., as Director-Regulatory Affairs from 2000 to 2004, CancerVax Corp., as Senior Director-Regulatory Affairs & Quality, Reata Pharmaceuticals, Inc., as Director-Regulatory Affairs & Quality Assurance, The Upjohn Co., as Principal, Novalar Pharmaceuticals, Inc., as VP-Regulatory Affairs & Quality Assurance, Spyre Therapeutics, Inc., as Vice President-Regulatory Affairs & Quality, Aquinox Pharmaceuticals, Inc., as VP-Global Regulatory Affairs & Quality Assurance from 2014 to 2017, Actelion Pharmaceuticals US, Inc., as Principal, Sumitovant Biopharma, Inc., as Senior Vice President & Head-Regulatory Affairs, and Verastem, Inc., as Senior Vice President & Head-Regulatory Affairs from 2023 to 2024.
Mr. Mitchell received his graduate degree from The Johns Hopkins University and undergraduate degree from Mississippi College.

Anciens postes connus de David Mitchell

Sociétés	Poste	Fin
VERASTEM, INC.	Conseiller Juridique Général	01/04/2024
SPYRE THERAPEUTICS, INC.	Conseiller Juridique Général	01/03/2019
Aquinox Pharmaceuticals, Inc.	Conseiller Juridique Général	15/03/2017
BIOGEN INC.	Conseiller Juridique Général	01/01/2004
Sumitovant Biopharma, Inc.	Conseiller Juridique Général	-